Delhi High Court refuses to direct Zydus to disclose manufacturing process of Sigrima: Gireesh Babu, New Delhi Saturday, July 26, 2025, 08:00 Hrs [IST] The Delhi High Court has sa ...

July 25, 2025 Submitted by NVNA and Hospice NVNA and Hospice recently received a $1 million gift from Cathy and Rick Roche.

Despite a new setback for Elevidys in Europe, Roche—which markets Sarepta’s gene therapy outside the U.S.—remains committed ...

Chief executive Thomas Schinecker believes the price of drugs in the USA could be lowered considerably if this model were ...

Roche’s move came against a backdrop of wider industry retreat from gene therapy, with Pfizer pulling its FDA-approved ...

As first-line treatments in metastatic HER2-positive breast cancer evolve, the firm expects its HER2 targeted therapies to remain integral to growth.

A direct-to-consumer program for its drugs could bring down higher U.S. drug prices while cutting out pharmacy benefit managers.

Pharmaceutical companies have been in talks with the U.S. government to figure out how to bring drug prices down after President Trump signed in May an executive order that ties U.S. prices to the ...

Roche reported better than expected first-half operating profit, driven by strong sales of breast cancer and asthma ...

Thomas Schinecker, CEO of Roche, discusses the company's earnings and what the pharmaceutical industry in Europe is doing to ...

Roche (RHHBY) plans direct-to-patient drug sales in the U.S. to avoid the influence from pharmacy benefit managers in product ...

Roche is considering selling its prescription medicines in the U.S. directly to consumers to lower costs for patients as part ...